Literature DB >> 21295634

Making 1+1=3: improving sedation through drug synergy.

Lawrence B Cohen.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21295634     DOI： 10.1016/j.gie.2010.10.027

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN： 0016-5107            Impact factor:   9.427


× No keyword cloud information.
  2 in total

1.  Nonanesthesiologist-administered propofol versus midazolam and propofol, titrated to moderate sedation, for colonoscopy: a randomized controlled trial.

Authors:  Javier Molina-Infante; Carmen Dueñas-Sadornil; Jose M Mateos-Rodriguez; Belen Perez-Gallardo; Gema Vinagre-Rodríguez; Moises Hernandez-Alonso; Miguel Fernandez-Bermejo; Ferran Gonzalez-Huix
Journal:  Dig Dis Sci       Date:  2012-05-22       Impact factor: 3.199

2.  Comparison between the recovery time of alfentanil and fentanyl in balanced propofol sedation for gastrointestinal and colonoscopy: a prospective, randomized study.

Authors:  Wai-Meng Ho; Chia-Ming Yen; Chin-Hung Lan; Chung-Yi Lin; Su-Boon Yong; Kai-Lin Hwang; Ming-Chih Chou
Journal:  BMC Gastroenterol       Date:  2012-11-21       Impact factor: 3.067
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.